Although the goal was to boost patient care, things took a dive when the company cut its full-year profit forecast and its stock value went down by half in the last quarter. It dropped 2.1% at the New York market open following the announcement, per Bloomberg.

“Brewer’s downfall may have been failing to manage expectations of how some of the moves, like the investment in Village MD, would likely impact company profits in the short term,” the outlet wrote.